DK1287832T3 - Anvendelse af antagonist af leukæmiinhiberende faktor - Google Patents

Anvendelse af antagonist af leukæmiinhiberende faktor

Info

Publication number
DK1287832T3
DK1287832T3 DK02016730T DK02016730T DK1287832T3 DK 1287832 T3 DK1287832 T3 DK 1287832T3 DK 02016730 T DK02016730 T DK 02016730T DK 02016730 T DK02016730 T DK 02016730T DK 1287832 T3 DK1287832 T3 DK 1287832T3
Authority
DK
Denmark
Prior art keywords
antagonist
inhibitory factor
leukemia inhibitory
administered
treatment
Prior art date
Application number
DK02016730T
Other languages
Danish (da)
English (en)
Inventor
Elizabeth A Luis
Napoleone Ferrara
Kathleen King
Jennie P Mather
Nicholas F Paoni
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1287832T3 publication Critical patent/DK1287832T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK02016730T 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor DK1287832T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42738395A 1995-04-24 1995-04-24
EP96913814A EP0830143B1 (de) 1995-04-24 1996-04-17 Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten

Publications (1)

Publication Number Publication Date
DK1287832T3 true DK1287832T3 (da) 2006-05-01

Family

ID=23694642

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96913814T DK0830143T3 (da) 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister
DK02016730T DK1287832T3 (da) 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK96913814T DK0830143T3 (da) 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister

Country Status (12)

Country Link
EP (2) EP0830143B1 (de)
JP (1) JPH11504332A (de)
AT (2) ATE313333T1 (de)
AU (1) AU702375B2 (de)
CA (1) CA2214636C (de)
DE (2) DE69626510T2 (de)
DK (2) DK0830143T3 (de)
ES (1) ES2254564T3 (de)
IL (1) IL117998A (de)
MX (1) MX9707939A (de)
WO (1) WO1996033740A1 (de)
ZA (1) ZA963274B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002519387A (ja) 1998-07-06 2002-07-02 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 体外受精のための組成物および方法
EP1549198A4 (de) * 2002-09-30 2007-03-28 Univ Duke Thymusatrophi
JP2011231014A (ja) * 2008-08-27 2011-11-17 Keiichi Fukuda 心不全の治療剤
EP2371860A1 (de) * 2010-04-05 2011-10-05 Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron Den humanen leukaemieinhibierenden Faktor (LIF) erkennender Antikörper und Verwendung von LIF-Antikörpern bei der Behandlung von Krankheiten im Zusammenhang mit ungewollter Zellproliferation
US10583191B2 (en) 2016-12-19 2020-03-10 Mosaic Biomedicals Slu Antibodies against LIF and uses thereof
EP3555132B1 (de) 2016-12-19 2023-11-15 Medimmune Limited Antikörper gegen lif und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4231393A (en) * 1992-05-08 1993-12-13 Genentech Inc. Antibodies to leukemia inhibitory factor
WO1995008550A1 (en) * 1993-09-24 1995-03-30 Abbott Laboratories Endothelin antagonists

Also Published As

Publication number Publication date
DE69635630D1 (de) 2006-01-26
DE69626510D1 (de) 2003-04-10
EP0830143B1 (de) 2003-03-05
AU5665896A (en) 1996-11-18
ES2254564T3 (es) 2006-06-16
IL117998A (en) 2001-04-30
JPH11504332A (ja) 1999-04-20
CA2214636A1 (en) 1996-10-31
ZA963274B (en) 1997-10-24
DK0830143T3 (da) 2003-06-16
DE69635630T2 (de) 2006-08-10
IL117998A0 (en) 1996-08-04
EP1287832A3 (de) 2003-04-16
DE69626510T2 (de) 2003-12-11
CA2214636C (en) 2009-12-22
AU702375B2 (en) 1999-02-18
EP0830143A1 (de) 1998-03-25
MX9707939A (es) 1997-12-31
ATE233570T1 (de) 2003-03-15
ATE313333T1 (de) 2006-01-15
WO1996033740A1 (en) 1996-10-31
EP1287832A2 (de) 2003-03-05
EP1287832B1 (de) 2005-12-21

Similar Documents

Publication Publication Date Title
DK0574457T3 (da) Antiviral nucleosidkombination
DE59104440D1 (de) Epiduralkanüle.
DE69103844D1 (de) Einstufiger Venenkatheter.
DE69206378D1 (de) Patientenliegetische.
DK485588A (da) Doseringsform omfattende hurtig (laege)middellevering efterfulgt af langsom (laege)middellevering
DE68920545D1 (de) Polyolefinlaminat mit hoher Festigkeit und hohem Elastizitätsmodul, das verbesserte Festkörper-Tiefziehfähigkeit aufweist.
IT8983533A0 (it) Dispositivo per la regolazione del frontale nei cassetti
DK557087D0 (da) Forbindelse til behandling af retrovirusinfektioner
DK1287832T3 (da) Anvendelse af antagonist af leukæmiinhiberende faktor
EP0642347A4 (de) Verwendung von 2-halo-adeninderivaten als therapeutische wirkstoffe gegen chronisch-myeloische leukämie.
NO880908D0 (no) Kombinasjonsterapi med bruk av antitumor immunotoksiner med tumornecrosefaktor.
DE68913088D1 (de) Faserbehandlungszusammensetzung.
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
IT8519042A0 (it) Impiego di chinoloni nel trattamento di malattie cardiache.!
DE3860847D1 (de) Schwenkbare schubduese mit variablem, verstellbarem querschnitt.
DE3886155D1 (de) Anthracyclin-Derivate mit Inhibitorwirkung gegen die reverse Transkriptase des menschlichen Immundefizienzvirus.
DE69103824D1 (de) Patientenliegetische.
FI952018A0 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
ITMO930019V0 (it) Tavoletta filtro per cannule di gruppi di aspirazione dentistici.
RU96120518A (ru) Средство для лечения больных хроническим простатитом
CO5170411A1 (es) Terapia para la leucemia mielocitica cronica
ES1022839Y (es) Bragas monouso.
ES1007222Y (es) Punta estimuladora perfeccionada.
ES1019711Y (es) hito de arista perfeccionado.